Paper
0
SAT-198 ASC41, a selective THRβ agonist significantly reduces liver fat and ALT in biopsy-confirmed MASH patients after 12-week treatment: an interim analysis of a 52-week serial liver biopsy study
Authors
Jian‐Gao Fan,Junping Shi
Hong Wang,Ming‐Hua Zheng,Jinjun Chen,Yao Xie,Fangfang Lv,Stewart Wang,Ling Yang,Qing Xie,Yueqiu Gao,Chuanwu Zhu,Xuebing Yan,Qiya Huang,Bin Xu,Fu‐Yu Li,Honglian Bai,Hong Deng,Airong Hu,Xin Gao,Guo‐Xin Hu,Hong You,Hong Tang,Min Zhang,Xiaoling Chi,Qin Du,Xiumei Wu,Hongzhou Lu,Yuguo Zhang,Guizhou Zou,Huanwei Zheng,Yujuan Guan,Yue Chen,Hua Ye,Tianhuang Liu,Yue-Mei Yan,Jinzi Wu
+35 authors
,Yubao GuanJournal
Published
Jun 1, 2024
Show more
Save
Tip0
TipSave
Abstract
Add an abstract to this paper
Help us improve the quality of this page by adding an abstract.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.
